Global Tumor Models Market Expected to Hit $3.57 Billion by 2030, Growing at 10.8% CAGR

The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What is the Market Size Outlook for the Tumor Models Market?
The tumor models market size has grown rapidly in recent years. It will grow from $2.13 billion in 2025 to $2.37 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to limited availability of advanced tumor models, reliance on traditional 2d cell cultures, growing cancer research funding, increasing prevalence of cancer, adoption of orthotopic and heterotopic models.

The tumor models market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in organ-on-a-chip and 3d spheroid technologies, increasing focus on personalized oncology treatments, expansion of contract research organizations (cros) in tumor research, rising pharmaceutical R&D expenditure, integration of ai and big data analytics in tumor model studies. Major trends in the forecast period include increasing use of 3d tumor spheroids and organ-on-a-chip models, rising demand for personalized medicine and targeted cancer therapies, expansion of xenograft and genetically engineered mouse models (gemms), growth in drug discovery and toxicology studies using tumor models, collaboration between pharmaceutical companies and academic institutions.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

What Are the Most Significant Drivers Affecting the Tumor Models Market Expansion?
The growing demand for personalized medicine is expected to propel the growth of the tumor models market going forward. Personalized medicine refers to a medical model that uses information about a person’s genes and lifestyle environment to tailor treatments and healthcare to their specific needs. The rise of personalized medicine is due to people preferring health technologies that offer real-time monitoring and treatment plans customized to their unique biology. Tumor models help personalized medicine by allowing researchers and clinicians to test and predict how individual patients' tumors will respond to specific treatments as experimental platforms that mimic the behavior of real human cancers, enabling a more tailored approach to therapy. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the tumor models market.

What Are the Key Segments in the Tumor Models Market?
The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models
2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies
3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:
1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models
2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models
3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models
4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Which Trends Are Most Likely to Influence Tumor Models Market Growth in the Next Decade?
Major companies operating in the tumor models market are focusing on developing advanced solutions, such as tumor spheroid models, to enhance the physiological relevance and predictive accuracy of in vitro cancer models. Tumor spheroid models refer to three-dimensional (3D) aggregates of cancer cells that spontaneously form spherical structures in culture. For instance, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, launched novel 3D cell technology to accelerate cancer therapeutic drug discovery. It offers unique features such as advanced 3D tumor spheroid and organoid models that closely mimic the tumor microenvironment, high-throughput screening capabilities for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics for enhanced predictive accuracy and deeper insights into therapeutic responses.

Who Are the Leading Players in the Tumor Models Market?
Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Get the full tumor models market report here:
https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

How Does Tumor Models Market Growth Vary Across Major Regions?
North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company